A Pilot Feasibility and Acceptability Study of Yoga/Meditation on the Quality of Life and Markers of Stress in Persons Living with HIV Who Also Use Crack Cocaine

Journal of Alternative and Complementary Medicine

Volumn 21, Issue 3, 2015, Pages 152-158

  Agarwal, Ram P ^a   Kumar, Adarsh ^a   Lewis, John E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PRASTERONE SULFATE; COCAINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMPACT OF EVENTS SCALE; MALE; MENTAL STRESS; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PERCEIVED STRESS SCALE; PILOT STUDY; PRIORITY JOURNAL; PROGRAM FEASIBILITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SHORT FORM 36; YOGA; CHEMICALLY INDUCED; COMPLICATION; FEASIBILITY STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDITATION; PSYCHOLOGY; THERAPY; VIROLOGY;

ADULT; COCAINE-RELATED DISORDERS; CRACK COCAINE; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDITATION; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; YOGA;

EID: 84924815225     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2014.0112     Document Type: Article

References (55)

1. Bonadies V. A yoga therapy program for AIDS-related pain and anxiety: implications for therapeutic recreation. Ther Recreation J 2004;38:148-166.
2. Rodger AL, Lodwick R, Schechter M, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS Care 2013;27:973-979.
3. Furuya-Kanamori L, Kelly MD, McKenzie SJ. Comorbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysis. PLoS One 2013;8:e78403.
4. Green GS, Smith R. The psychosocial and health care needs of HIV-positive people in the United Kingdom: a review. HIV Med 2004;5:5-46.
5. Rosenfield BD. Pain in ambulatory AIDS patients: impact of pain on psychology functioning and quality of life. Pain 1996;68:323-328.
6. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298:1685-1687.
7. Cole SW, Naliboff BD, Kemeny ME, et al. Impaired responses to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A 2001;98:12695-12700.
8. Nair MP, Saiyed ZM, Nair N, et al. Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol 2009;4:129-139.
9. Baum MK, Rafie C, Lai S, et al. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr 2009;50:93-99.
10. Barroso J. Self-care activities of long-term survivors of acquired immunodeficiency syndrome. Holist Nurs Pract 1995;10:44-53.
11. Antoni MH, Cruess DG, Klimas N, et al. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional naïve T-cells (CD4+ CD45RA+ CD29+). Am J Psychiatry 2002;159:143-145.
12. Antoni MH, Carrico AW, Duran RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med 2006;68:143-151.
13. Dhalla S, Chan KJ, Montaner JS, et al. Complementary and alternative medicine use in British Columbia - a survey of HIV positive people on antiretroviral therapy. Complement Ther Clin Pract 2006;12:242-248.
14. Lorenc A, Robinson N. A review of the use of complementary and alternative medicine and HIV: issues for patient care. AIDS Patient Care STDS 2013;27:503-510.
15. Owen-Smith A, DePadilla L, DiClemente R. The assessment of complementary and alternative medicine use among individuals with HIV: a systematic review and recommendations for future research. J Altern Complement Med 2011;17:789-796.
16. Ladenheim D, Horn O, Werneke U, et al. Potential health risks of complementary alternative medicines in HIV patients. HIV Med 2008;9:653-659.
17. Hart J. An overview of clinical applications of therapeutic yoga. Altern Complement Ther 2008;14:29-32.
18. Yang K. A review of yoga programs for four leading risk factors of chronic diseases. Evid Based Complement Alternat Med 2007;4:487-491.
19. DiStasio SA. Integrating yoga into cancer care. Clin J Oncol Nurs 2008;12:125-130.
20. Monti DA, Sufian M, Peterson C. Potential role of mindbody therapies in cancer survivorship. Cancer 2008;112(11 Suppl):2607-2616.
21. Innes KE, Vincent HK. The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review. Evid Based Complement Alternat Med 2007;4:469-486.
22. Selvamurthy W, Sridharan K, Ray US, et al. A new physiological approach to control essential hypertension. Indian J Physiol Pharmacol 1998;42:205-213.
23. Sivasankaran S, Pollard-Quintner S, Sachdeva R, et al. The effect of a six-week program of yoga and meditation on brachial artery reactivity: do psychosocial interventions affect vascular tone? Clin Cardiol 2006;29:393-398.
24. Arora S, Bhattacharjee J. Modulation of immune response in stress by Yoga. Int J Yoga 2008;1:45-55.
25. Cade WT, Reeds DN, Mondy KE, et al. Yoga life style intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors. HIV Med 2010;11:379-388.
26. Curtis K, Osadchuk A, Katz J. An eight-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia. J Pain Res 2011;4:189-201.
27. Dalmida SG, Holstad MM, Diiorio C, et al. Spiritual wellbeing, depressive symptoms, and immune status among women living with HIV/AIDS. Women Health. 2009;49:119-143.
28. Jam S, Imani AH, Foroughi M, et al. The effect of mindfulness based stress reduction (MBSR) program in Iranian HIV/AIDS patients: a pilot study. Acta Med Iran 2010;48:101-106.
29. Brazier A, Mulkins A, Verhoef M. Evaluating a yogic breathing and meditation intervention for individuals living with HIV/AIDS. Am J Health Promot 2006;20:192-195.
30. Creswell JD, Myers HF, Cole SW, et al. Mindfulness meditation training effects on CD4+ T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behave Immun 2009;23:184-188.
31. Solberg EE, Halvarsen R, Sundgot-Borgen J, et al. Meditation: a modulator of the immune response to physical stress? A brief report. Br J Sports Med 1995;29:255-257.
32. Fitzpatrick AL, Standish LJ, Berger J, et al. Survival in HIV positive adults practicing psychological or spiritual activities for one year. Altern Ther Health Med 2007;13:18-20, 22-24.
33. Beitel M, Genova M, Schuman-Olivier Z, et al. Reflections by inner-city drug users on a Buddhist-based spirituality-focused therapy. Am J Orthopsychiatry 2007;77:1-9.
34. Antoni MH. Stress management and psychoneuroimmunology in HIV infection. CNS Spectr 2003;8:40-51.
35. Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med 1992;327:1360-1365.
36. Kumar M, Kumar AM, Morgan R, et al. Abnormal pitui-tary- adrenocortical response in early HIV-1 infection. J Acquir Immune Defic Syndr 1993;6:61-65.
37. Membreno L, Irony I, Dere W, et al. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1987;65:482-487.
38. Chittiprol S, Kumar AM, Shetty KT, et al. HIV-1 clade C infection and progressive disruption in the relationship between cortisol, DHEAS and CD4 cell numbers: a two-year follow-up study. Clin Chim Acta 2009;409:4-10.
39. Kumar M, Kumar AM, Waldrop D, et al. HIV-1 infection and its impact on the HPA axis, cytokines, and cognition. Stress 2003;6:167-172.
40. Bell C, Metsch LR, Vogenthaler N, et al. Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care. J Acquir Immune Defic Syndr 2010;54:376-380.
41. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
42. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
43. Horowitz MJ, Wilner NR, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;4:209-218.
44. Kumar AM, Solano MP, Fernandez JB, et al. Adrenocortical response to ovine corticotrophin-releasing hormone in young men: cortisol measurement in matched samples of saliva and plasma. Hormone Res 2005;64:55-60.
45. Nagendra HR. Pranayama: The Art and Science. Banglore, India: Swami Vivekananda Yoga Prakasana; 2003.
46. Rama S. Meditation and Its Practice. Honesdale, PA: Himalayan International Institute of Yoga Sciences and Philosophy of the USA; 1992.
47. Chhatre S, Metzger DS, Frank I, et al. Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV. AIDS Care 2013;25:1291-1297.
48. McCain NL, Munjas BA, Munro CL, et al. Effects of stress management on PNI-based outcomes in persons with HIV disease. Res Nurs Health 2003;26:102-117.
49. Cruess DG, Antoni MH, Kumar M, et al. Reductions in salivary cortisol are associated with mood improvement during relaxation training among HIV-seropositive men. J Behav Med 2000;23:107-122.
50. Gonzalez A, Mimiaga MJ, Israel J, et al. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS Behav 2013;17:168-173.
51. Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav 2007;11:185-194.
52. Gardner EM, Sharma S, Peng G, et al. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS 2008;22:75-82.
53. Ospina MB, Bond K, Karkhaneh M, et al. Clinical trials of meditation practices in health care: characteristics and quality. J Altern Complement Med. 2008;14:1199-1213.
54. Hofmann SG, Sawyer AT, Witt AA, et al. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol 2010;78:169-183.
55. Nagarathna R, Nagendra HR. Yoga for bronchial asthma: a controlled study. Br Med J. 1985;291:1077-1079.